When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China

Author(s)

Zhou D1, Shao T2, Shao H2, Tu Y2, Tang Y2, Zhou J2, Malone DC3, Tang W2
1China Pharmaceutical University, Nanjing, China, 2China Pharmaceutical University, Nanjing, 32, China, 3University of Utah, Skaggs College of Pharmacy, Salt Lake City, UT, USA

Presentation Documents

Background: The world is dealing with both the declining vaccine effectiveness and increasing demand for booster doses to address SARS-CoV-2 virus mutations. This study explore various vaccination strategies to model reduce illness and determine those approaches that are cost-effective.

Methods: We established a transmission-dynamic-model to predict the spread of SARS-CoV-2 infection within 6 month period under three strategies: discontinuing vaccination; prioritizing second shot; and prioritizing booster dose. Outcomes of interest included infected cases, deaths, quality adjusted life days (QALDs). We considered the impact of social factors in the scenario analysis, and also included uncertain assumptions and parameters in the sensitivity analysis.

Findings: The number of avoided cases/severe cases with prioritizing second shot and prioritizing booster dose was 462/88 and 585/61 compared with discontinuing vaccination (2357/269) within 180 days. Prioritizing booster vaccination could potentially save 895∙71 QALYs and USD −$12,564∙19. The scenario analysis indicated that prioritizing second shot may become more effective and beneficial with increased mask-wearing rate and nucleic acid tests requirement.

Interpretation: When both rates of quarantine and mask-wearing were relatively high, prioritizing booster vaccination was less costly and could avoid more infections. However, prioritizing second shot could avoid more cases of critically-ill and could override the latter under stricter epidemic control, indicating that booster vaccination has great limitations in improving the protective effect against SARS-CoV-2 mutation. This study provides evidence for effectiveness and cost-effectiveness regarding whether and how to provide vaccine shots and also confirms that strict epidemic controls remain valuable in countries with insufficient vaccine supply.

Keywords: COVID-19 vaccines, vaccination priority, dynamic transmission model

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Value in Health, Volume 25, Issue 6, S1 (June 2022)

Code

EPH172

Topic

Epidemiology & Public Health

Topic Subcategory

Public Health

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×